Cost-utility analysis of home parenteral nutrition.
An economic evaluation of home parenteral nutrition (HPN) for intestinal failure is presented.
The cost-utility of HPN and factors affecting the cost-utility ratio were examined to determine whether current practice is the most efficient way of treating intestinal failure.
Quality-adjusted life-years (QALYs) gained were measured using a validated health status questionnaire.
The cost of treating a patient with intestinal failure was calculated, and marginal cost per QALY gained ratios were obtained.
The cost per QALY for an average patient was approximately £68 975, but the value for patients over 55 years of age of about £126 865 compared with approximately £58 233 for those under 44 years.
Treating a patient in hospital rather than at home increased the estimated cost per QALY to approximately £190 000.
The current practice of home care is about 65 per cent more cost-effective than hospital care.
Mots-clés Pascal : Alimentation, Voie parentérale, A domicile, Evaluation, Qualité vie, Coût, Analyse avantage coût, Homme, Réanimation, Nutrition, Economie santé
Mots-clés Pascal anglais : Feeding, Parenteral administration, At home, Evaluation, Quality of life, Costs, Cost benefit analysis, Human, Resuscitation, Nutrition, Health economy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0421757
Code Inist : 002B27B07. Création : 10/04/1997.